Metropolitan Life Insurance Company (MetLife)’s Amyris Inc. AMRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-11,076
Closed -$11.4K 2478
2023
Q2
$11.4K Hold
11,076
﹤0.01% 2231
2023
Q1
$15.1K Sell
11,076
-860
-7% -$1.23K ﹤0.01% 2010
2022
Q4
$18.3K Hold
11,936
﹤0.01% 2064
2022
Q3
$34.9K Buy
11,936
+6,238
+109% +$17K ﹤0.01% 1707
2022
Q2
$10.5K Sell
5,698
-5,139
-47% -$15.1K ﹤0.01% 2302
2022
Q1
$47.2K Sell
10,837
-30,972
-74% -$139K ﹤0.01% 1636
2021
Q4
$226K Sell
41,809
-570
-1% -$5.32K ﹤0.01% 1942
2021
Q3
$582K Sell
42,379
-3,444
-8% -$49.3K 0.01% 1356
2021
Q2
$750K Buy
45,823
+15,389
+51% +$229K 0.01% 1234
2021
Q1
$581K Buy
30,434
+2,197
+8% +$31.9K 0.01% 1329
2020
Q4
$174K Sell
28,237
-4,361
-13% -$13.9K ﹤0.01% 2023
2020
Q3
$95.2K Buy
32,598
+9,291
+40% +$34.1K ﹤0.01% 2247
2020
Q2
$99.5K Buy
+23,307
New +$77.5K ﹤0.01% 2256

Other funds holding AMRS

Metropolitan Life Insurance Company (MetLife)'s AMRS Position: Q3 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Amyris Inc. (AMRS) in Q3 2023, closing a stake of 11,076 shares — an estimated $11.4K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AMRS in Q2 2020 and held it in 13 quarters. The position peaked at $750K in Q2 2021. 18 funds tracked by Wall St. Rank hold AMRS as of Q3 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Amyris Inc. position as of Q3 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 11,076 Amyris Inc. shares in Q3 2023, an estimated $11.4K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Amyris Inc. in Q2 2020 and held it in 13 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Amyris Inc. position peaked at $750K in Q2 2021.
  • 18 funds tracked by Wall St. Rank held Amyris Inc. as of Q3 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2023, filed 14 Nov 2023.